1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Market Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Research Data
2.1.1 Secondary Research Key Data From Secondary Sources
2.1.2 Primary Research Key Data From Primary Sources
2.2 Market Estimation Methodology
2.2.1 Product-Based Market Estimation
2.2.2 Application-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary (Page No. – 28)
4 Premium Insights (Page No. – 32)
4.1 NGS-Based RNA-Sequencing: Market Overview
4.2 NGS-Based RNA-Sequencing Market, By Product & Service, 2019 vs. 2024 (USD Million)
4.3 NGS-Based RNA-Sequencing Market Share, By Technology, 2019 vs. 2024
4.4 NGS-Based RNA-Sequencing Market, By Application, 2019 vs. 2024 (USD Million)
4.5 NGS-Based RNA-Sequencing Market Share, By End User, 2019 vs. 2024
4.6 Geographical Snapshot of the NGS-Based RNA-Sequencing Market
5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers Advantages of RNA-Seq Over Conventional Technologies Increasing Number of RNA-Seq Grants Growing Number of Research Activities Involving RNA-Seq Rapid Growth in Precision Medicine
5.2.2 Restraints Lack of Skilled Professionals Standardization Concerns of RNA-Seq in Diagnostic Testing
5.2.3 Opportunities Increasing Applications of RNA-Seq in Research Cancer Research Agricultural Research
5.2.4 Challenges Storage & Interpretation of Sequencing Data Analysis of RNA-Seq Data for the Detection of Novel Transcripts
6 NGS-Based RNA-Sequencing Market, By Product & Service (Page No. – 41)
6.1 Introduction
6.2 RNA Sequencing Platforms & Consumables
6.2.1 Increasing Availability of Platforms and Growing Consumable Usage Have Ensured the High Share of This Segment
6.3 Sample Preparation Products
6.3.1 Sample Preparation is the First Step of an NGS Workflow
6.3.2 Sample Preparation Products, By Workflow Library Preparation & Target Enrichment Quality Control
6.3.3 Sample Preparation Products, By Method Manual Sample Preparation Microfluidic Sample Preparation Robotic Liquid Handling Sample Preparation
6.4 RNA Sequencing Services
6.4.1 Lack of Infrastructure and Expertise Among End Users has Driven Demand for Services
6.5 Data Analysis, Storage & Management
6.5.1 Integration of Cloud Computing and Bioinformatics, Among Other Advancements, is Contributing to Market Growth
7 NGS-Based RNA-Sequencing Market, By Technology (Page No. – 48)
7.1 Introduction
7.2 Sequencing By Synthesis
7.2.1 Sbs Technology Enables the Highest Production of Base Pairs in A Short Period of Time
7.3 Ion Semiconductor Sequencing
7.3.1 Ion Semiconductor Sequencing Platforms Possess High-Throughput Capabilities
7.4 Single-Molecule Real-Time Sequencing
7.4.1 Smrt Sequencing Produces Results in A Short Time and at Lower Costs
7.5 Nanopore Sequencing
7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct RNA-Sequencing Capabilities
8 NGS-Based RNA-Sequencing Market, By Application (Page No. – 54)
8.1 Introduction
8.2 Expression Profiling Analysis
8.2.1 Increasing Need for Improved Prognosis of Patients to Propel Market Growth
8.3 Small RNA Sequencing
8.3.1 Rising Need for Accurate Diagnostic Analysis to Support Market Growth
8.4 De Novo Transcriptome Assembly
8.4.1 Increasing Cancer Cases is Expected to Drive This Application Segment
8.5 Variant Calling & Transcriptome Epigenetics
8.5.1 Complicated RNA-Seq Data Analysis May Hamper the Growth of This Segment
9 NGS-Based RNA-Sequencing Market, By End User (Page No. – 60)
9.1 Introduction
9.2 Research & Academia
9.2.1 Increasing Number of Collaborations Between NGS Market Players and Academic & Research Institutes to Propel Market Growth
9.3 Hospitals & Clinics
9.3.1 Increasing Adoption of NGS Systems in Hospitals & Clinics to Drive Market Growth
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Consolidation Between Biotech & Pharma Companies and NGS Market Players to Propel Market Growth
9.5 Other End Users
10 NGS-Based RNA-Sequencing Market, By Region (Page No. – 67)
10.1 Introduction
10.2 North America
10.2.1 US Favorable Funding Scenario and Growing R&D Activity in the US are Driving Market Growth
10.2.2 Canada Government Initiatives for Genome Research Will Boost the Adoption of NGS Sequencing Technology
10.3 Europe
10.3.1 Germany Germany Dominates the NGS-Based RNA-Sequencing Market in Europe
10.3.2 UK Strong Presence of NGS Organizations and Supportive Initiatives Will Drive Market Growth in the UK
10.3.3 France Growing Awareness on Applications of High-Throughput Sequencing in Genetic Characterization Will Support Market Growth
10.3.4 RoE
10.4 Asia Pacific
10.4.1 China Strong Base of Established Players and Favorable Government Initiatives Account for China’s Large Market Share
10.4.2 Japan Growing Awareness and Rising Incidence of Genetic Disorders are Driving Demand for NGS-Based RNA-Seq in Japan
10.4.3 India Rising Awareness and Player Interest in India Will Drive Market Growth
10.4.4 RoAPAC
10.5 Latin America
10.5.1 Brazil High Hiv Prevalence in Brazil has Driven Demand for NGS in Research
10.5.2 Mexico Economic Growth and Support for Infrastructural Development Will Drive Market Growth in Mexico
10.5.3 RoLA
10.6 Middle East & Africa
10.6.1 Lack of Infrastructure has Stifled Market Growth in the MEA
11 Competitive Landscape (Page No. – 101)
11.1 Introduction
11.2 Competitive Leadership Mapping
11.2.1 Terminology/Nomenclature Visionary Leaders Innovators Dynamic Differentiators Emerging Companies
11.3 Competitive Scenario (2015-2019)
11.4 NGS-Based RNA-Sequencing Market Ranking, By Top Three Market Players (2018)
12 Company Profiles (Page No. – 109)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Agilent Technologies
12.2 BGI Group
12.3 Eurofins Scientific
12.4 GENEWIZ (Part of Brooks Automation)
12.5 Hamilton Company
12.6 Illumina
12.7 Nugen Technologies (Part of Tecan Trading AG)
12.8 Oxford Nanopore Technologies
12.9 Perkinelmer
12.10 Psomagen
12.11 QIAGEN
12.12 F. Hoffmann-La Roche AG
12.13 Takara Bio
12.14 Thermo Fisher Scientific
12.15 Zymo Research
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 148)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details